After the founding father of Theranos Elizabeth Holmes loses her calling against her conviction for fraud of crimes this week, a former public prosecutor of the US Ministry of Justice has a key role in the combination of the technology entrepreneur in prison for the Silicon Valley entrepreneur: Don't be like Holmes.

“The snack bars are quite obvious,” said John Botic, now the lawyer of a distinguished law firm in Bay Area, who at the tip of Holmes' process as CEO “so fear of failure” she was able to do all the things. “

The 41-year-old Holmes was convicted in January 2022 in four cases of crimes for fraud of hundreds of millions of dollars by her Blood test startup from Palo's old test. The jurors heard that they incorrectly proposed that their technology was used for military helicopters, and she admitted to the witness stand that she had applied logos of pharmaceutical companies and applied to internal Theranos documents that had shared an offer of the credibility of her company in what claimed prosecutors had shared. It was convicted of more than 11 years in prison, with a current publication date in March 2032.

The 42-year-old BOSTIC, now a partner in the Palo Alto headquarters of the Global law firm Cooley, is working on the defense and investigation on the employee. He met on Tuesday with this news organization to discuss Holmes' failed appeal and the criminal proceedings and the four -month legal proceedings. His comments were processed for length and clarity.

Q: Why did Holmes fail 'appeal procedure?
A: In the course of such a court proceedings, so many disputes between the parties appear on legal interpretation issues or factual accuracy or the admissibility of evidence. The Court, of course, makes decisions everywhere, acts as a referee and calls balls and strikes. This means that there will always be something about which you can argue from an appellate court. We in the government team and everyone else in this room have worked hard to make it a fair process.

Q: In which teachings would you say that Holmes' case applies to entrepreneurs from Silicon Valley and the Tech industry?

A: There can be a temptation to fake it until you have made it – this is a saying that was associated with this case. And especially in the vicinity of startups in Silicon Valley, which is so competitive, where so many startups fail, there is an incentive for founders to accelerate things with the way in which they may be inaccurate or excessively optimistic. The case of Theranos is obviously a memory that there is a line that cannot be crossed there and that it is really important to be careful and careful and honest in communication about new technologies, (and) of the company's services.

Q: Has the fact that she has not motivated herself to make the public prosecutor more difficult?

A: From the perspective of the government and from the perspective of the law, the reason of a defendant takes into account the fraud fraud, not in the analysis, be it for himself or in favor of himself or in favor of someone else or, in this case, to help a company increase a company or increase a company's chance of success.

Q: What was Holmes' most convincing evidence of your defense?
A: I thought the defense did a great job to show their commitment to the company and how hard they and others worked towards the success of the company. However, I think that this did not affect the result, since the claim was not that this was a sham company, but only that lies were told in connection with the company and what it could do.

Q: What do you see as the strongest evidence against Holmes?
A: In a fraud, the critical proof of what the defendant intended is. It can be difficult to prove what was in the head of a person. There were indications that Holmes knew that some things she said about were not true, and there were also some indications of a change in documents that I had very easy to understand for the jury.

Q: When did you hear from Elizabeth Holmes for the first time?
A: When the Wall Street Journal article emerged in October 2015. This was the first negative reporting on Holmes and Theranos. The week when I joined the (Ministry of Justice) was the week when the article came out.

Q: Did you expect the case to land in your desk?

A: At that point I had no reason to assume that I’d ultimately work on this examination that might turn right into a law enforcement. But I used to be definitely interested by once I first examine it at a private level, after which in fact also through the lens of a public prosecutor since it identified possible fraud.

Q: How did you get the case?
A: For a number of reasons, I fit well with this case, including that I actually have a scientific background. I used to be a significant of molecular biology. As you saw within the study, on this case there have been some really technical problems that involve these (blood tests) and their validity and their statistical performance, the variety of tests that would perform various devices. It gave me a little bit of ahead and I believe it made it easier for me to send the jury a few of these concepts.

Q: Was there a turning point within the attempt that made Holmes on a trajectory for a wrongdoer judgment?
A: I actually have never seen this process as a single star wire or a single crucial moment or proof that all the things else is switched on. The government investigated tens of million pages with documentary evidence. Dozens of individuals, perhaps a whole lot, were interviewed in reference to the investigation. The process … took several months. I believe it was the load of the general evidence that did the work and never a selected piece.

Q: Were you surprised that she took a position?
A: I used to be not surprised. Because fraud cases are so dependent that the jury understood what was within the defendant's head after they did, there is usually no substitute for a accused who puts the viewpoint and offers its side of history. It's a high moment. It is a time when the jury and the judge are particularly vigilant to search out out what it happens from what happens on the witness stand.

The appeal of imprisoned Theranos fraudster Elizabeth Holmes is scheduled to be heard in federal court in San Francisco on Tuesday.

The notorious founding father of the now-defunct Palo Alto blood-testing startup is serving a lengthy sentence in a minimum-security Texas prison. Theranos, once valued at $9 billion, claimed its devices could run greater than a thousand tests — for the whole lot from cancer and diabetes to pregnancy and HIV infection — using just just a few drops of blood from a finger prick.

Holmes' legal team and prosecutors will argue the case at 9 a.m. within the U.S. Court of Appeals for the Ninth Circuit. She filed an appeal in late 2022, 11 months after a jury found her guilty on 4 counts of defrauding Theranos investors. She desires to have her conviction and 11-year prison sentence overturned, which might trigger a brand new trial.

Attorneys for Holmes, 40, said in a December 2022 court filing that the criminal case, which was heard in U.S. District Court in San Jose and led to guilty verdicts, was “replete with grounds for appeal.”

Those points, her legal team claimed, included alleged errors by Judge Edward Davila, who oversaw her case and trial. Holmes claimed Davila improperly allowed the jury to listen to about regulatory actions against Theranos and her company's reversal of all test results of its troubled “Edison” machines. Those events occurred after Holmes had made all “relevant” statements to investors, and the jury mustn’t have heard about them, Holmes's lawyers argued.

Holmes, a Stanford University dropout, founded Theranos in 2003 and built it right into a high-profile company backed by a few of America's richest people: Oracle co-founder Larry Ellison, media mogul Rupert Murdoch and Walmart's Walton family. Theranos faced poor oversight from a board full of luminaries akin to former U.S. Secretaries of State Henry Kissinger and George Shultz and former U.S. Secretaries of Defense James Mattis and William Perry.

A series of revelations within the Wall Street Journal starting in 2015 led to an investigation by U.S. federal authorities and a settlement with the U.S. Securities and Exchange Commission (SEC) through which Holmes was fined $500,000 and barred from serving as an officer or director of a publicly traded company for 10 years. In 2018, federal prosecutors charged her with fraud.

Ten months after her conviction, Davila sentenced Holmes, who has two young children with hotel heir Billy Evans, to 11 years and three months in prison. She surrendered to Camp Bryan federal prison, about 100 miles from Houston, on May 30, 2023, as U.S. Bureau of Prisons inmate number 24965-111.

Updates from the Bureau of Prisons show her sentence has been reduced by about two years and she or he is anticipated to be released in August 2032. Federal prisoners can reduce their sentence by 54 days for every year they’re incarcerated in the event that they meet behavioral standards, and so they can further reduce their sentence by completing programs to cut back recidivism and take part in “productive activities,” the bureau said.

Holmes won’t appear on the hearing in person or by video since the three-judge panel that hears oral arguments in federal court appeals is often attended only by lawyers and the court doesn’t allow for the presence of incarcerated people, a court spokesman said Tuesday.

Federal criminal complaints Success at very low pricesThat's the federal court system. If Holmes loses, she could appeal to the U.S. Supreme Court, but its justices hear only about 100 to 150 appeals a yr out of the greater than 7,000 it normally has to review. accordingly the court system.

Theranos founder Elizabeth Holmes has had her sentence reduced by greater than 4 months, in keeping with the US Bureau of Prisons.

Holmes, 40, was sentenced to 11 years and three months in prison for defrauding investors in her now-defunct Palo Alto blood testing startup. On May 30 last yr, she began her sentence on the Bryan Federal Penitentiary Camp in Texas.

In July, the prison agency estimated her expected release date was Dec. 29, 2032. As of Monday, her expected release date from the minimum security facility is Aug. 16, 2032, the agency said.

Inmates can receive additional release from their sentence by participating in recidivism reduction programs and “productive activities.”

Holmes' previous scheduled release date was apparently based on a credit of 54 days for every year of her sentence, suggesting that the August 2032 date reflects participation in prison programs.

Scheduled release dates are subject to alter. In California state prisons, inmates convicted of nonviolent crimes can achieve this reduce their sentences by half through good behavior and participation in prison programs.

Holmes' fall from high-flying CEO, value billions on paper, to prisoner 24965-111 has attracted worldwide attention. In January 2022, after a four-month trial, she was convicted of 4 counts of fraud by a jury in U.S. District Court in San Jose. Jurors heard that Holmes misrepresented Theranos' financial condition and the performance of its problematic blood testing machines. Prosecutors put investors' losses at greater than $878 million. The jury convicted Holmes of roughly $144 million in losses.

Judge Edward Davila handed down her verdict in November 2022 and later ordered her to pay greater than $450 million in restitution.

The mother of two is appealing her conviction and sentence.